04:43 , Nov 30, 2018 |  BC Week In Review  |  Company News

Alvotech grants Fuji rights to biosimilar portfolio in Japan

Alvotech ehf (Reykjavik, Iceland) granted Fuji Pharma Co. Ltd. (Tokyo:4554) exclusive rights to commercialize Alvotech's biosimilar portfolio in Japan. Fuji will be responsible for registration and commercialization of the biosimilars. Alvotech CEO Rasmus Rojkjaer told...
23:54 , Aug 7, 2017 |  BC Extra  |  Company News

Management tracks: Pfenex, Alvotech, uniQure

Biosimilars company Pfenex Inc. (NYSE-M:PFNX) named Evert Schimmelpennink CEO, president and secretary. He succeeds interim CEO Patrick Lucy, who will continue as CBO. Rasmus Rojkjaer was named CEO at biosimilar company Alvotech ehf (Reykjavik, Iceland),...
08:00 , Dec 16, 2013 |  BC Week In Review  |  Company News

Alvogen, Alvotech biosimilars news

Alvogen and undisclosed external investors will invest $250 million in Alvotech, which will use the money to develop and manufacture a portfolio of undisclosed biosimilar mAbs for the global market. Alvotech said its pipeline of...